Antioxidants preserve vision in retina disease

Article

Consumption of antioxidants may enable retinal degeneration patients to preserve vision even while vascular abnormalities continue to exist, concluded a study published online ahead of print by the Journal of Clinical Investigation.

Consumption of antioxidants may enable retinal degeneration patients to preserve vision even while vascular abnormalities continue to exist, concluded a study published online ahead of print by the Journal of Clinical Investigation.

Professor Martin Friedlander, MD, PhD of Scripps Research Institute, US and colleagues examined mice with dysfunctional VLDL receptors, which imitate abnormal retinal neovascularisation associated with death of the photoreceptor cells in humans. Such symptoms are associated with conditions such as retinal angiomatous proliferation (RAP) and macular telangiectasia (MacTel).

The team found that abnormalities of the intraretinal vasculature and associated neuronal cell death were correlated with increased oxidative stress markers; there oxidative stress markers were mediated either by nutritional antioxidant supplements or by targeted topical antioxidant delivery, although the presence of antioxidants had no impact on the existing vascular abnormalities.

Therefore the researchers concluded that, by reducing oxidative stress, photoreceptor cells could be preserved and functional vision maintained by RAP and MacTel patients even while retinal vasculature is not improved.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.